@article{JSS3737,
author = {Doniel Drazin and Eric Choi and Alfredo Garcia and Tarush Rustagi},
title = {Bone morphogenic proteins are a good choice for select spinal surgeries and merit further research},
journal = {Journal of Spine Surgery},
volume = {3},
number = {1},
year = {2017},
keywords = {},
abstract = {Autologous bone graft with bone obtained from the iliac crest has long been used in spinal fusion surgery (1). Reports of morbidity associated with harvesting iliac crest bone graft (ICBG) have led to an ongoing quest for bone graft substitutes. Ever since Urist introduced the use of bone morphogenic protein (BMP) in 1960, BMPs have been the subject of debate and various research projects (2). BMP-2 (Infuse, Medtronics) has been FDA approved for anterior lumbar interbody fusion. BMP-7 [Osigraft (OS) and OP1 Putty, Stryker] has only been granted a Humanitarian exemption for revision posterolateral fusion in compromised patients.},
issn = {2414-4630}, url = {https://jss.amegroups.org/article/view/3737}
}